The potential for therapy of immune disorders with gene therapy.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Pediatric clinics of North America

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0031-3955(05)70277-7PMID 11131002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer.

  2000cited by this paper
• Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

  2000cited by this paper
• Expression of human Wiskott–Aldrich syndrome protein in patients’ cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins

  2000cited by this paper
• Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38− subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV

  2000cited by this paper
• IMMUNODEFICIENCY CAUSED BY ADENOSINE DEAMINASE DEFICIENCY

  2000cited by this paper
• Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy.

  2000cited by this paper
• Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

  1999cited by this paper
• Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency.

  1999cited by this paper
• Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

  1999cited by this paper
• KDR receptor: a key marker defining hematopoietic stem cells.

  1999cited by this paper
• Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.

  1999cited by this paper
• Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott–Aldrich syndrome patients carrying ‘null’ mutations

  1999cited by this paper
• Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach.

  1999cited by this paper
• The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

  1998cited by this paper
• Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1.

  1998cited by this paper
• Role of class-II major histocompatibility complex (MHC)-antigen-positive donor leukocytes in transfusion-induced alloimmunization to donor class-I MHC antigens.

  1998cited by this paper
• Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

  1998cited by this paper
• Identification of a Human Immunodeficiency Virus Type 2 (HIV-2) Encapsidation Determinant and Transduction of Nondividing Human Cells by HIV-2-Based Lentivirus Vectors

  1998cited by this paper
• Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.

  1998cited by this paper
• Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria.

  1998cited by this paper
• Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor.

  1998cited by this paper
• Correction of Respiratory Burst Activity in X-Linked Chronic Granulomatous Cells to Therapeutically Relevant Levels after Gene Transfer into Bone Marrow CD34+ Cells

  1998cited by this paper
• The CD34 Molecule and Hematopoietic Progenitor Cell Studies ‐ a Challenge in Clinical Medicine

  1998cited by this paper
• Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.

  1998cited by this paper
• Partial V(D)J recombination activity leads to Omenn syndrome.

  1998cited by this paper
• Biology of CD34+CD38- cells in lymphohematopoiesis.

  1998cited by this paper
• Gene transfer vectors derived from equine infectious anemia virus

  1998cited by this paper
• γc Gene Transfer in the Presence of Stem Cell Factor, FLT-3L, Interleukin-7 (IL-7), IL-1, and IL-15 Cytokines Restores T-Cell Differentiation From γc(−) X-Linked Severe Combined Immunodeficiency Hematopoietic Progenitor Cells in Murine Fetal Thymic Organ Cultures

  1998cited by this paper
• Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice

  1998cited by this paper
• T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates

  1998cited by this paper
• Restoration of lymphocyte function in Janus Kinase 3-deficient mice by retroviral-mediated gene transfer

  1998cited by this paper
• Human Immunodeficiency Virus Type 2 Lentivirus Vectors for Gene Transfer: Expression and Potential for Helper Virus-Free Packaging

  1998cited by this paper
• HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.

  1998cited by this paper
• A newly discovered class of human hematopoietic cells with SCID-repopulating activity

  1998cited by this paper
• gammac gene transfer in the presence of stem cell factor, FLT-3L, interleukin-7 (IL-7), IL-1, and IL-15 cytokines restores T-cell differentiation from gammac(-) X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures.

  1998cited by this paper
• Clinical spectrum of X-linked hyper-IgM syndrome.

  1997cited by this paper
• Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

  1997cited by this paper
• Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.

  1997cited by this paper
• Identification of the homologous beige and Chediak–Higashi syndrome genes

  1997cited by this paper
• Genetic correction of p67phox deficient chronic granulomatous disease using peripheral blood progenitor cells as a target for retrovirus mediated gene transfer.

  1997cited by this paper
• Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

  1997cited by this paper
• Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

  1997cited by this paper
• Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector.

  1997cited by this paper
• Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species

  1997cited by this paper
• Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.

  1997cited by this paper
• Structural and functional basis for JAK3-deficient severe combined immunodeficiency.

  1997cited by this paper
• Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins.

  1996cited by this paper
• Gene Therapy for AIDS Using Retroviral Mediated Gene Transfer to Deliver HIV-1 Antisense TAR and Transdominant Rev Protein Genes to Syngeneic Lymphocytes in HIV-1 Infected Identical Twins. National Institutes of Health, Bethesda, Maryland

  1996cited by this paper
• Reconstitution of T cell receptor signaling in ZAP-70-deficient cells by retroviral transduction of the ZAP-70 gene

  1996cited by this paper
• Identification of the homologous beige and Chediak–Higashi syndrome genes

  1996cited by this paper
• Retroviral-mediated gene correction for X-linked severe combined immunodeficiency.

  1996cited by this paper
• In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation.

  1996cited by this paper
• Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene.

  1996cited by this paper
• RAG Mutations in Human B Cell-Negative SCID

  1996cited by this paper
• Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expression.

  1996cited by this paper
• gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function.

  1996cited by this paper
• Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.

  1996cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell

  1996cited by this paper
• Bone marrow gene transfer in three patients with adenosine deaminase deficiency.

  1996cited by this paper
• Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.

  1996cited by this paper
• Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.

  1996cited by this paper
• High-titer packaging cells producing recombinant retroviruses resistant to human serum

  1995cited by this paper
• Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients

  1995cited by this paper
• The current status of gene therapy using hematopoietic stem cells.

  1995cited by this paper
• Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development

  1995cited by this paper
• Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression.

  1995cited by this paper
• T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years

  1995cited by this paper
• Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

  1995cited by this paper
• CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease.

  1994cited by this paper
• Generation of high-titer pseudotyped retroviral vectors with very broad host range.

  1994cited by this paper
• The Molecular Basis of X‐Linked Severe Combined Immunodeficiency: The Role of the Interleukin‐2 Receptor γ Chain as a Common γ Chain, γc

  1994cited by this paper
• CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease

  1994cited by this paper
• Gene therapy using retroviral vectors.

  1994cited by this paper
• The Use of Gene‐Modified Tumor‐Infiltrating Lymphocytes for Cancer Therapy

  1994cited by this paper
• Expression of Human CD18 in Murine Granulocytes and Improved Efficiency for Infection of Deficient Human Lymphoblasts

  1993cited by this paper
• Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.

  1993cited by this paper
• Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.

  1993cited by this paper
• Human gene therapy.

  1992cited by this paper
• An in vivo animal model of gene therapy for leukocyte adhesion deficiency.

  1991cited by this paper
• Lymphocytes as cellular vehicles for gene therapy in mouse and man.

  1991cited by this paper
• Purine nucleoside phosphorylase deficiency.

  1991cited by this paper
• Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus

  1991cited by this paper
• The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990.

  1990cited by this paper
• European experience of bone-marrow transplantation for severe combined immunodeficiency.

  1990cited by this paper
• The ADA human gene therapy clinical protocol.

  1990cited by this paper
• Retrovirus Packaging Cells

  1990cited by this paper
• Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines.

  1989cited by this paper

• Primary Immunodeficiencies

  2008cites this paper
• High Incidence of Severe Combined Immune Deficiency in the Eastern Province of Saudi Arabia

  2006cites this paper
• Immunodeficiency Syndromes: Gene Therapy

  2006cites this paper
• The role of signal transducers and activators of transcription in T inflammatory bowel diseases.

  2003cites this paper
• Alterations in the Immune Response

  2003cites this paper
• Rapid prenatal diagnosis of X‐linked chronic granulomatous disease using a denaturing high‐performance liquid chromatography (DHPLC) system

  2003cites this paper
• Diagnóstico fenotípico de las inmunodeficiencias primarias en Antioquia, Colombia, 1994-2002

  2002cites this paper
• Gastrointestinalof Non-AIDS

  2002cites this paper
• Primary cellular immunodeficiencies.

  2002cites this paper
• Gastrointestinal manifestations of non-AIDS immunodeficiency

  2002cites this paper
• Primary immunodeficiency diseases: dissectors of the immune system

  2002cites this paper
• Primary immunodeficiency disorders: antibody deficiency.

  2002cites this paper
• Gene therapy for human severe combined immunodeficiencies.

  2002cites this paper
• Gene therapy for human severe combined immunodeficiencies.

  2001cites this paper